Detection of large expansions in myotonic dystrophy type 1 using triplet primed PCR

Frontiers in Genetics

Volumn 5, Issue APR, 2014, Pages

  Singh, Susmita ^a   Zhang, Amy ^a   Dlouhy, Stephen ^a   Bai, Shaochun ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allelic expansion; CTG; Myotonic dystrophy type 1 (DM1); Trinucleotide repeat; Triplet repeat primed PCR

Indexed keywords

ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC ANALYSIS; GENETIC COMPATIBILITY; HUMAN; MYOTONIC DYSTROPHY; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SOUTHERN BLOTTING; TRINUCLEOTIDE REPEAT PRIMED POLYMERASE CHAIN REACTION;

EID: 84901005388     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2014.00094     Document Type: Article

References (11)

1. Bird, T. (2013). Myotonic Dystrophy Type 1. GeneReviews. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1165/.
2. Chen, L., Hadd, A., Sah, S., Filipovic-Sadic, S., Krosting, J., Sekinger, E., et al. (2010). An information-rich CGG repeat primed PCR that detects the full range of fragile X expanded alleles and minimizes the need for southern blot analysis. J. Mol. Diagn. 12, 589-600. doi: 10.2353/jmoldx.2010.090227.
3. Gharehbaghi-Schnell, E. B., Finsterer, J., Korschineck, I., Mamoli, B., and Binder, B. R. (1998). Genotype - phenotype correlation in myotonic dystrophy. Clin. Genet. 53, 20-26. doi: 10.1034/j.1399-0004.1998.531530105.x.
4. Johnson, N. E., and Heatwole, C. R. (2012). Myotonic dystrophy: from bench to bedside. Semin. Neurol. 32, 246-254. doi: 10.1055/s-0032-1329202.
5. Prior, T. W., American College of Medical Genetics (ACMG) Laboratory Quality Assurance Committee. (2009). Technical standards and guidelines for myotonic dystrophy type 1 testing. Genet. Med. 11, 552-555. doi: 10.1097/GIM.0b013e3181abce0f.
6. Radvansky, J., Ficek, A., Minarik, G., Palffy, R., and Kadasi, L. (2011). Effect of unexpected sequence interruptions to conventional PCR and repeat primed PCR in myotonic dystrophy type 1 testing. Diagn. Mol. Pathol. 20, 48-51. doi: 10.1097/PDM.0b013e3181efe290.
7. Santoro, M., Masciullo, M., Pietrobono, R., Conte, G., Modoni, A., Bianchi, M. L., et al. (2013). Molecular, clinical, and muscle studies in myotonic dystrophy type 1 (DM1) associated with novel variant CCG expansions. J. Neurol. 260, 1245-1257. doi: 10.1007/s00415-012-6779-9.
8. Tassone, F., Pan, R., Amiri, K., Taylor, A. K., and Hagerman, P. J. (2008). A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragileX (FMR1) gene in newborn and high-risk populations. J. Mol. Diagn. 10, 43-49. doi: 10.2353/jmoldx.2008.070073.
9. Turner, C., and Hilton-Jones, D. (2010). The myotonic dystrophies: diagnosis and management. J. Neurol. Neurosurg. Psychiatry 81, 358-367. doi: 10.1136/jnnp.2008.158261.
10. Warner, J. P., Barron, L. H., Goudie, D., Kelly, K., Dow, D., Fitzpatrick, D. R., et al. (1996). A general method for the detection of large CAG repeat expansions by fluorescent PCR. J. Med. Genet. 33, 1022-1026. doi: 10.1136/jmg.33.12.1022.
11. Zeesman, S., Carson, N., and Whelan D. T. (2002). Paternal transmission of the congenital form of myotonic dystrophy type 1: a new case and review of the literature. Am. J. Med. Genet. 107, 222-226. doi: 10.1002/ajmg.10141.